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Abstract
Globally, an estimated 300 million people have asthma, presenting a considerable and increasing burden of disease
for healthcare systems, families, and patients themselves. Despite two decades of guidelines, asthma seems to
remain not optimally controlled in a substantial proportion of people. The achievement of asthma control is the
result of the interaction among different variables concerning the disease pattern and patients’ and physicians’
knowledge and behavior. It is well known that adherence to treatment increases in parallel to patient education.
There is now a growing interest in the use of digital information technologies to promote asthma control and
improve outcomes. Mobile health, or mHealth, refers to mobile devices, medical sensors, and communication
technologies that can enhance chronic disease care and monitoring. Aim of this review was to evaluate the web
resources nowadays available and to analyze the published studies about the web-based instruments used to
improve asthma knowledge, control asthma outcomes. In general, studies revealed that the technology is well
accepted. Interactive asthma technology may be, in addition, of help in reaching populations difficult to reach, such
as inner city populations. The number of tools and apps available continues to increase, and agencies such as the
FDA, become involved in their regulation, thus the mHealth landscape will continue to evolve. Although asthma
tools and apps have great potential to improve care for asthma, the proof of data reproducibility, the
demonstration of effectiveness, and the privacy issues still represent the major technical problems.
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Background
Globally, an estimated 300 million people have asthma,
presenting a considerable and increasing burden of disease
for healthcare systems, families, and patients. Over the
past 20 years, there has been a concerted effort to reduce
morbidity and mortality related to chronic diseases, in-
cluding bronchial asthma. These efforts led to many new
initiatives to develop clinical practice guidelines, to con-
duct research to fill the gaps in the guidelines, and to con-
tinuously revise the guidelines themselves according to
updated experimental data [1]. Despite two decades of
guidelines, a substantial proportion of people do not
achieve a proper asthma control. [2].
Furthermore, the poor adherence to monitoring and
treatment is a significant factor associated to the poor
control of disease. In addition, the misuse of metered-dose
inhalers is associated with decreased asthma stability [3].
New information about asthma phenotypes/endotypes
and new tools to monitor disease activity, including bio-
markers and epigenetic/“omics” markers, along with tech-
nology systems to monitor asthma control hold some
promise to better identify the gaps between diagnosis and
management [4]. The concept of “personalized medicine”
recently emerged, and other indicators suggest that this
could significantly improve asthma management, because
the response to therapy is largely variable [5]. These ad-
vances should prompt the evolution of new treatments to
further reduce the burden of disease. It is now imperative
to continue also to focus on possibly reducing the burden
of asthma and preventing its onset. The available research
and surveillance show a persistent underuse of evidence-
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based management strategies to control asthma. The
achievement of asthma control results from the inter-
action among different variables concerning the disease
pattern and patients’ and physicians’ knowledge and be-
havior. The failure in asthma control thus results from the
complex interaction among different variables, such as
patient-related factors (i.e., adherence to treatment, alex-
ithymia, and coping strategies) [6]. An optimal asthma
control may be reached through a tailored treatment plan,
taking into account the complexity of most factors that
contribute to achieve and maintain this objective. Further-
more, it is known that the treatment adherence increases
with increased patient education [7] (Fig. 1). Efforts in bet-
ter monitoring asthma have been attempted, essentially by
mean of the web-based instruments. These include elec-
tronic medical records and health care provider surveil-
lance systems (Fig. 2). Mobile health (mHealth) refers to
mobile-based monitoring systems, including medical sen-
sors, and recording technologies that can enhance chronic
disease care [8]. Combining electronic medical records
with periodic measurements of pulmonary function may
improve the quality of monitoring disease activity and
progression [9, 10].
Web-based technologies to promote asthma control
and improve outcomes are currently studied and wel-
come. On the other hand, there is increasing evidence
that an improper and “addictive” use of the internet-
based resource (such as social networks) could have a
negative impact on asthma, either in term of control and
self-perception. The aim of this review was to evaluate
the web resources offered, and to analyze the published
studies about the interactive internet-based and mobile
device platforms to improve asthma knowledge, and/or
outcomes, and to highlight also the possible negative
effects of web-based instruments. These studies are cre-
ative and promising, but still at an early stage and, unfor-
tunately, characterized by small trials, showing variable
results [11].
Landscape and evolution of online searches
related to the medical world
Today, health information runs on the web. In the
Western world it has been observed that patients spend
more time online than at the doctor’s office to acquire
health information. One third of the American adults go
online to get information on a medical condition [12]. In
the United States it is estimated that patients undergo, on
average, three visits per year, but spend more than 52 h
online to get health information and medical advice. 59 %
of U.S. adults have looked online for health information in
the past year and 35 % of adults report they have used
internet for medical purposes (“online diagnosers”). 53 %
Fig. 1 Essential steps towards an individualized asthma treatment plan
Fig. 2 Potential network for obtain and improve information and
monitoring asthma
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of online diagnosed spoke with a clinician about what they
found online and 41 % of online diagnosers had their con-
dition confirmed by a clinician [12]. Fifty-two percent of
smart-phone owners have looked up health information
on their phone, compared with a 6 % of other cell phone
owners. 77 % of online health seekers say they began at a
search engine such as Google, Bing, or Yahoo [12]. In
Italy, a Censis research within the Forum for Biomedical
Research found that 32.4 % of Italians use Internet to ob-
tain health information; out of them 90.4 % search about
specific diseases, 58.6 % look for doctors and facilities and
However the internet has not undermined the family doc-
tor, who still remains the primary reference [13].
The impact of Social Networks on asthma/asthma
control
Several studies and expert opinions suggest that use of
internet-based media in general might have a beneficial
effect by enhancing communication, social connection,
and even technical skills [14]. The dramatic increase in
social network use, especially among adolescents and
young adults, is leading health care researchers to fur-
ther evaluate the effects of this new medium on the gen-
eral population and on people affected by chronic
diseases. In particular, internet-based resources can
offer a patient-friendly way to monitor a gven disease
and to improve adherence to treatment. At the moment,
the possible negative effects, seem to be counterba-
lanced by increasing evidence of a positive effect on
self-esteem [15]. On the other hand, Internet use was
thought to promote negative psychosocial well-being,
including depression and loneliness. Via social networks
adolescents can come into contact with inappropriate
contents, being unaware of online privacy issues. Other
problems include internet addiction and concurrent
sleep deprivation, as well as physical inactivity, which is
associated with an increased risk of obesity [16]. Re-
searchers recently proposed a new type of depression,
termed “Facebook depression” which develops when
preteens and teens spend long periods on social network
sites and then begin to experience symptoms of depres-
sion [17]. In 2010, the first case of asthma exacerbation
possibly triggered by the use of Facebook was reported,
and other cases concerning asthma were described [18].
Social networks in general could be a new source of psy-
chological stress and trigger exacerbations in depressed
asthmatic individuals. Therefore, this type of trigger
should be also taken into account when assessing asthma
exacerbations. Recent studies emphasized that the effect
of stressors is associated with an independent risk of de-
veloping asthma [19]. Stressful events can trigger asthma
exacerbations, but could also contribute to the develop-
ment of incident asthma. However, only few studies have
investigated the association between stressful events and
adult asthma prospectively [20]. Likewise, stress-related
personality traits (e.g., neuroticism and extraversion)
may increase asthma risk [21]. Psychological conditions
such as anxiety and depression have been frequently re-
ported in people with asthma and may, often associated
with a poorer control [22, 23]. The hypothesis explain-
ing this observation is that stressful life events may alter
the psychological, immunological, and endocrine sys-
tems via mechanisms that are still largely unknown [24].
In fact, asthma is a chronic inflammatory disease of the air-
ways, and many studies have linked stress and emotions to
inflammatory processes [25–27]. Mechanisms of airway
constriction (immune/inflammatory and cholinergic/vagal)
point to two possible psychobiologic pathways: (1) psycho-
neuroimmunologic, and 2) psychophysiologic (autonomic
nervous system). There are evidences supporting the role
of immune/inflammatory processes, involving the choliner-
gic system, as psychobiologic pathways [28]. Studies also
support the autonomic system involvement as impacting
on stress and depression in asthma [29, 30].
The evolution of mobile Apps for asthma/asthma
control
The number of medical apps greatly increased over the
past decade. As of 2012, there were more than 13,000
health care-related apps available to Apple iPhone users
and more than 6,000 available in the Android store [31].
Nowadays, the interest in mobile apps to manage
chronic conditions such as asthma is matched by the
recognition of the importance of quality and safety of
apps intended for patients’ use. Changes in mobile de-
vices and software have been accompanied by discus-
sions that have progressively involved clinicians [32, 33],
policy groups [34], and regulatory authorities [35]. There
is no accepted measure of app quality, and most apps
are not regulated or approved by the Federal Drug Ad-
ministration (FDA), European Medical Agency (EMA)
or guidelines. Mobile medical apps that the FDA would
regulate include apps that transform a mobile platform
into a regulated medical device; connect to an existing
device for purposes of controlling its operation, function,
energy source, and data transfer and storing [36]. In
order for medical doctors to recommend apps to their
patients, efficacy and effectiveness evaluations are neces-
sary; however, few such evaluations are currently avail-
able. A Cochrane review of smartphone and tablet self-
management apps for asthma in 2013 found only 2 trials
of phone-based asthma self-management interventions
that included randomized controlled trials to assess for
efficacy [37]. The Authors deemed the utility of apps to
be inconclusive and were unable to advise clinicians on
the efficacy on apps for asthma self-management. Re-
cently, Chen Wu et al. evaluated the currently available
categories of asthma-related apps, grouped according to
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specific functions by the two most popular smartphone
brands (Apple iPhone and Google Android), which at
February 2014, comprised more than 90 % of the U.S.
smartphone market [38]. Of 209 total asthma-related
apps, 50 % were available for Android, 34 % for iPhone,
and 16 % for both devices. Up to 58 % of apps were free
and 39 % were paid. The cost of apps ranges from $0.99
to $29.99, and some (3 %) had free but less comprehen-
sive versions available. The largest proportion of
asthma-related apps (52 %) focus on teaching and train-
ing in techniques related to managing asthma. Most of
these apps (39 %) teach users alternative methods for
treating asthma, such as yoga postures, acupressure, and
breathing exercises. Many apps (22 %) provide general
information about asthma through text, video, and/or
audio formats. Other apps (17 %) provide treatment in-
formation, and some explain inhalation techniques. Ap-
proximately 18 % of apps are designed for health care
providers rather than for patients. Systematic analysis on
all the apps identified by the Authors, however, evi-
denced some limitations about measurements of quality,
effectiveness, and explanations of privacy risks. The
same conclusions were reported by Huckvale et al. [39].
These Authors reported that: 1) between 2011 and 2013,
the number of asthma apps increased from 93 to 191,
despite withdrawal of 25 % of existing apps; 2) the newer
apps were no more likely than those available in 2011 to
include comprehensive information; 3) 13 % of all apps,
were dedicated to the management of acute asthma, and
recommended procedures unsupported by evidence; 4)
despite the increase of apps targeting specific skills, such
as acute asthma management (12 to 23) and inhaler
technique (from 2 to 12), the proportion consistent with
guidelines (17 %) and inhaler instructions (25 %), re-
spectively, was low, and most apps provided only basic
information about asthma (50 %) or simple diary func-
tions (24 %). In addition, under a methodological view-
point it was shown that theory-based web interventions
works better than those non theory-based [40]. In con-
clusion, as the number of apps made available continues
to increase, the mHealth landscape will continue to
change. Although apps have great potential to improve
care for asthma, most of them are currently limited in
their quality, effectiveness, and protection of user data.
In other words, it is unclear if substantial clinical bene-
fits can be obtained in a landscape dominated by low-
quality generic information apps.
Asthma control and electronic asthma action plan
tools (eAAP)
An asthma action plan (AAP) is a tool designed to assist
asthmatic patients with self-management of their dis-
ease. Asthma guidelines recommend that all patients
with asthma be provided with a plan that includes
instructions for daily management and for recognizing
and handling exacerbations [41]. AAPs are particularly
helpful for patients with poorly controlled asthma. Some
studies demonstrate that asthmatics receiving an AAP as
part of their self-management education have higher sat-
isfaction with their care, increased medication adher-
ence, and fewer acute care visits compared with patients
with no AAP [42–44]. Furthermore, a Cochrane review
of 36 studies showed significant reductions in both
Emergency Department visits (relative risk, 0.82; 95 %
confidence interval [CI], 0.73–0.94) and hospitalizations
(relative risk, 0.64; 95 % CI, 0.50–0.82) among patients
with an AAP as part of optimal self-management com-
pared with usual care [45]. Asthma action plans assist
patients with self-management, but provider compliance
with this recommendation is limited in part because of
guideline complexity. The complexity of asthma man-
agement require also innovative approaches to improve
quality gaps and patient outcomes. Technology can be
leveraged to link and filter the guidelines to providers at
the point of care, resulting in increased adherence and
reduced exacerbations. By incorporating technology into
providers’ asthma workflow, these solutions may in-
crease the likelihood of patients receiving guideline-
based recommendations and an AAP, thus facilitating
their active involvement in their own care. Recently,
Kuhn et al. developed an electronic AAP decision sup-
port tool (eAAP) within the electronic health record
(EHR) that could streamline the evidence-based NHLBI
guidelines for providers, while also creating an individual-
ized handout for patients to be used as self-management
plan [46]. The eAAP was developed in 4 phases. Phase 1
involved the creation of a web-based eAAP prototype by
researchers from the General Practitioners. This prototype
facilitated the ability to make design revisions quick and
easy. To embed this tool into the electronic health record,
a multidisciplinary team was engaged in phase 2. Once
ready for production, the eAAP entered phase 3, where it
was piloted at 5 outpatient primary care practices from
December 2012 through July 2013. During this pilot stage,
the development team continued to enhance the eAAP
based on feedback from end users. Finally, in August
2013, the eAAP entered phase 4: dissemination with wide-
spread implementation at over 100 primary care practices
across the health care system. The final eAAP product
meets the general criteria of typical AAPs in that it in-
structs patients in how to manage asthma on a daily basis
and what to do in of the case of worsening symptoms or
exacerbations. In addition, the eAAP provides instantan-
eous determination of peak flow thresholds calculated
using an algorithm based on patient demographic. Be-
tween December 2012 and September 2014, 5174 patients
with asthma received eAAPs. The total number of eAAP
recipients re-presents approximately 10 % of the health
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care system’s asthma population. Compared with the con-
trols (eAAP nonrecipients), eAAP recipients did not differ
significantly in the odds of ED visits or hospitalizations for
asthma at 3, 6, or 12 months. Children receiving an eAAP,
however, had 33 % lower odds of receiving an oral steroid
for asthma (12-month odds ratio [OR], 0.67; 95 % CI,
0.56–0.81). The combined exacerbation outcome was also
significant (12-month OR, 0.73; 95 % CI, 0.61–0.87).
Equivalent pre/post measures for adults were not statisti-
cally significant at 6 or 12 months, likely because of the
smaller sample size; however, a 41 % decrease in out-
patient oral steroids (P < .001) and a 34 % reduction in any
exacerbation (P < .05) occurred 3 months after receiving
an eAAP. This eAAP not only satisfies the traditional ele-
ments of basic AAPs but also leverages technology to im-
prove the efficiency of care delivery and adherence to
evidence-based guidelines with decision support capabil-
ities to improve asthma control. This study supports exist-
ing evidence that patient self-management plays an
important role in reducing asthma exacerbations.
Conclusions
Internet, social networks, and Apps quickly are becom-
ing universal in modern medical practice. Data sharing,
online reviews and ratings, and digital privacy concerns
likely will become a part of most every physician’s prac-
tice, regard-less of his or her use of social networks. The
widespread use of internet-based media brings unprece-
dented connectivity that opens new horizons for physi-
cians, ranging from interactions with patients, to
communication with peers and the public, to novel ap-
proaches to research. This review of published clinical
trials and other studies using the Internet and mobile
devices to promote asthma education and improve
asthma outcomes/control reveals innovation and promise.
However, despite the appeal of technology-based asthma
interventions, most of these studies are still in the early
pilot stages with small sample sizes and mixed results.
There were no studies found using currently commercially
available asthma mobile device applications or social net-
working health sites. In general, studies revealed that the
technology was well received [47–52]. Interactive asthma
technology may be especially helpful in reaching popu-
lations previously considered to be difficult to reach,
such as inner city populations [48–54] and those with
more severe or poorly controlled asthma [55–57]. Pa-
tients with well-controlled asthma were less likely to
use the technology [54]. Most studies were short-term
and those that lasted longer tended to show a decline in
use over time [48-55].
It is controversial whether or not these information
technologies will assist persons to self-manage their
asthma or completely take overall decision making. A
promising approach may be to combine the use of
information technology with coping peer support.
Innovation in asthma information technology-based inter-
ventions requires a multidisciplinary approach among
asthma doctors, behavior change specialists, health com-
munication experts, and computer science sophistication.
Other health professionals that may be an important re-
source to involve patients in the use of WEB in the man-
agement of asthma may be represented by pharmacists. It
should be stressed, however, that the enthusiasm for using
information technologies to promote asthma control must
be supported by randomized trials to determine efficacy
and cost effectiveness. Randomized, controlled trials with
larger and more diverse sample sizes, objectively mea-
sured medical and behavioral outcomes, long-term follow-
up, evaluation of cost effectiveness, and assessment of the
technical feasibility are undoubtedly in the near future.
The results of such studies are urgently needed. The ease
with which these technologies fit into our daily lives, and
the importance of ongoing patient management of chronic
diseases suggest that these creative and innovative ap-
proaches could prove to be a valuable adjunct to effective
clinical practice.
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